StartUp Health January 13, 2026
This week’s global health innovation funding highlights new investments in Alzheimer’s Moonshot Community members Alamar Biosciences and Pramana Pharmaceuticals, followed by a surge of rounds across precision medicine, AI-driven drug discovery, digital health, medical devices, and care delivery throughout North America, Europe, and the Middle East.
This week, two StartUp Health community members announced new funding:
Alamar Biosciences, a Fremont, CA-based company that powers precision proteomics to enable the earliest detection of disease, closed $50M in an oversubscribed convertible notes financing. The round included funding from accounts advised by T. Rowe Price Investment Management, Braidwell, Illumina Ventures, and Sands Capital. The financing will support the continued commercial advancement of Alamar’s precision proteomics platform. <source>
Pramana Pharmaceuticals, a Vancouver, BC, Canada-based...
Today's Sponsors
Today's Sponsor